Jci_page_head_homepage_01 Jci_page_head_homepage_02
Andrea Jurisicova, Asako Taniuchi, Han Li, Yuan Shang, Monica Antenos, Jacqui Detmar, Jing Xu, Tiina Matikainen, Adalberto Benito Hernández, Gabriel Nunez, Robert F. Casper
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3971–3978 doi:10.1172/JCI28493
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Effect of maternal treatment with PAHs on the ovarian follicle endowment in female offspring.

(A) Morphological appearance of ovaries from 3-week-old female daughters of mothers exposed to vehicle only (CC), PAH exposure (cumulative dose of 6 mg/kg) before pregnancy (PC), PAH exposure (cumulative dose of 6 mg/kg) during lactation (CP), and PAH exposure (cumulative dose of 12 mg/kg) both before pregnancy and during lactation exposure (PP). (B) Quantitative representation of the morphometric analysis of the ovarian pool for nonapoptotic oocyte-containing primordial (resting) and primary (growing) follicles in different treatment groups is expressed as mean ± SEM. Each treatment group shown represents combined data obtained from at least 2 female offspring per litter from each treated mother: CC, n = 11; PC, n = 18; CP, n = 11; PP, n = 15. Effectiveness of AHR antagonist was assessed in mothers from the PP group supplemented with resveratrol (PPR), or mothers from the CC group (vehicle) supplemented with resveratrol (R) (cumulative dose of 120 mg/kg). Two to three females per litter from each mother were subjected to morphometric analysis (R, n = 6; PPR, n = 9). *P < 0.05 relative to control; **P < 0.05 relative to all treatment groups.